All Stories

  1. Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function

    Article • Journal of Thrombosis and Haemostasis, October 2025, Elsevier

    Marie-Christine Morel-Kopp

  2. Platelet Counting and Platelet Dimension Measurements

    Article • January 2025, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  3. Functional Testing for Heparin-Induced Thrombocytopenia Using Whole Blood Multiplate Impedance Aggregometry

    Article • January 2023, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  4. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia

    Article • Pathology, October 2022, Elsevier

    Marie-Christine Morel-Kopp

  5. The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume

    Article • Platelets, March 2022, Taylor & Francis

    Marie-Christine Morel-Kopp

  6. Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients

    Article • Hämostaseologie, June 2021, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  7. An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group

    Article • Pathology, February 2020, Elsevier

    Marie-Christine Morel-Kopp

  8. The effect of metoprolol and aspirin on cardiovascular risk in bereavement: A randomized controlled trial

    Article • American Heart Journal, February 2020, Elsevier

    Marie-Christine Morel-Kopp

  9. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

    Article • Journal of Thrombosis and Haemostasis, December 2019, Wiley

    Dr Marie Lordkipanidzé, Marie-Christine Morel-Kopp

  10. The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature

    Article • Research and Practice in Thrombosis and Haemostasis, December 2019, Wiley

    Marie-Christine Morel-Kopp

  11. Diagnosis and management of heparin‐induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New ZealandHITWriting Group

    Article • The Medical Journal of Australia, June 2019, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Marie-Christine Morel-Kopp, Dr Emmanuel J Favaloro

  12. Optimising the laboratory diagnosis of heparin-induced thrombocytopenia (HIT)

    Article • Pathology, February 2018, Elsevier

    Marie-Christine Morel-Kopp

  13. Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thromboses

    Article • Internal Medicine Journal, January 2018, Wiley

    Marie-Christine Morel-Kopp

  14. N -methyl-d -aspartate receptor mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines

    Article • Research and Practice in Thrombosis and Haemostasis, December 2017, Wiley

    Marie-Christine Morel-Kopp

  15. Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding

    Article • Journal of Thrombosis and Haemostasis, December 2017, Wiley

    david rabbolini, Marie-Christine Morel-Kopp

  16. Mean platelet diameter measurements to classify inherited thrombocytopenias

    Article • International Journal of Laboratory Hematology, November 2017, Wiley

    david rabbolini, Marie-Christine Morel-Kopp

  17. Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia

    Article • Platelets, November 2017, Taylor & Francis

    david rabbolini, Dr robert j bird, Marie-Christine Morel-Kopp, WALTER CHEN

  18. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger

    Article • Journal of Thrombosis and Haemostasis, October 2017, Wiley

    david rabbolini, Marie-Christine Morel-Kopp

  19. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?

    Article • Research and Practice in Thrombosis and Haemostasis, August 2017, Wiley

    david rabbolini, Marie-Christine Morel-Kopp

  20. GFI1B variants associated with thrombocytopenia

    Article • Platelets, June 2017, Taylor & Francis

    david rabbolini, Marie-Christine Morel-Kopp

  21. The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study

    Article • Aging Clinical and Experimental Research, March 2017, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  22. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis

    Article • Platelets, February 2017, Taylor & Francis

    Marie-Christine Morel-Kopp

  23. Mean platelet diameter measurements to classify inherited thrombocytopenias

    Article • Pathology, February 2017, Elsevier

    david rabbolini, Marie-Christine Morel-Kopp

  24. Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH

    Article • Journal of Thrombosis and Haemostasis, November 2016, Wiley

    Marie-Christine Morel-Kopp

  25. Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study

    Article • Cardiology and Therapy, February 2016, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  26. Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay

    Article • Journal of Veterinary Emergency and Critical Care, January 2016, Wiley

    Marie-Christine Morel-Kopp

  27. Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation

    Article • Cellular Signalling, September 2015, Elsevier

    Maggie Kalev-Zylinska, Marie-Christine Morel-Kopp

  28. Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1

    Article • Blood, August 2015, American Society of Hematology

    david rabbolini, Marie-Christine Morel-Kopp

  29. Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

    Article • Annals of Hematology, August 2015, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  30. Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury

    Article • Molecular Endocrinology, August 2015, Endocrine Society

    Marie-Christine Morel-Kopp

  31. The Effect of Omega-3 Polyunsaturated Fatty Acids on Fibrin and Thrombin Generation in Healthy Subjects and Subjects with Cardiovascular Disease

    Article • Seminars in Thrombosis and Hemostasis, February 2015, Thieme Publishing Group

    Dr Bradley J McEwen, Marie-Christine Morel-Kopp

  32. Next generation sequencing using a candidate gene array for the diagnosis of uncharacterised inherited macrothrombocytopenias

    Article • Pathology, January 2015, Elsevier

    david rabbolini, Marie-Christine Morel-Kopp

  33. Inherited Macrothrombocytopenias

    Article • Seminars in Thrombosis and Hemostasis, August 2014, Thieme Publishing Group

    david rabbolini, Marie-Christine Morel-Kopp

  34. Platelets are not all gray in GFI1B disease

    Article • Clinical Genetics, July 2014, Wiley

    Marie-Christine Morel-Kopp

  35. Spectrum of the Mutations in Bernard-Soulier Syndrome

    Article • Human Mutation, July 2014, Hindawi Publishing Corporation

    Dr Basma Hadjkacem, Marie-Christine Morel-Kopp

  36. Clinical Application of Fibrinolytic Assays

    Article • May 2014, IntechOpen

    Marie-Christine Morel-Kopp

  37. N-methyl-d-aspartate receptors amplify activation and aggregation of human platelets

    Article • Thrombosis Research, May 2014, Elsevier

    Maggie Kalev-Zylinska, Marie-Christine Morel-Kopp

  38. Evaluation and modification of the overall hemostasis potential assay for use with canine plasma

    Article • American Journal of Veterinary Research, December 2013, American Veterinary Medical Association (AVMA)

    Marie-Christine Morel-Kopp

  39. GFI1Bmutation causes a bleeding disorder with abnormal platelet function

    Article • Journal of Thrombosis and Haemostasis, November 2013, Wiley

    Marie-Christine Morel-Kopp

  40. Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital

    Article • Blood Coagulation & Fibrinolysis, June 2013, Wolters Kluwer Health

    Marie-Christine Morel-Kopp

  41. Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay

    Article • Thrombosis Research, May 2013, Elsevier

    Marie-Christine Morel-Kopp

  42. Effects of Omega-3 Polyunsaturated Fatty Acids on Platelet Function in Healthy Subjects and Subjects with Cardiovascular Disease

    Article • Seminars in Thrombosis and Hemostasis, January 2013, Thieme Publishing Group

    Dr Bradley J McEwen, Marie-Christine Morel-Kopp

  43. Effect of Early Bereavement on Heart Rate and Heart Rate Variability

    Article • The American Journal of Cardiology, November 2012, Elsevier

    Marie-Christine Morel-Kopp

  44. Reduced T helper and B lymphocytes in Parkinson's disease

    Article • Journal of Neuroimmunology, November 2012, Elsevier

    Marie-Christine Morel-Kopp

  45. Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA)

    Article • Thrombosis and Haemostasis, August 2012, Schattauer GmbH

    Dr Bradley J McEwen, Marie-Christine Morel-Kopp

  46. Platelets and innate inflammation in pregnancy

    Article • Journal of Reproductive Immunology, May 2012, Elsevier

    Marie-Christine Morel-Kopp

  47. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study

    Article • Thorax, February 2012, BMJ

    Dr Bradley J McEwen, Marie-Christine Morel-Kopp

  48. Evaluating Heparin-Induced Thrombocytopenia: The Old and the New

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  49. Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT

    Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  50. Severe FX deficiency caused by a previously unidentified 4-bp deletion compound heterozygous with a large deletion involving FVII and FX genes

    Article • Haemophilia, November 2011, Wiley

    Marie-Christine Morel-Kopp

  51. Inflammatory and thrombotic changes in early bereavement: a prospective evaluation

    Article • European Journal of Preventive Cardiology, September 2011, SAGE Publications

    Marie-Christine Morel-Kopp

  52. False negative or false positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: reply to a rebuttal

    Article • Journal of Thrombosis and Haemostasis, July 2011, Wiley

    Marie-Christine Morel-Kopp

  53. Haemodynamic Changes During Early Bereavement: Potential Contribution to Increased Cardiovascular Risk

    Article • Heart Lung and Circulation, February 2011, Elsevier

    Marie-Christine Morel-Kopp

  54. Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays

    Article • International Journal of Laboratory Hematology, December 2010, Wiley

    Marie-Christine Morel-Kopp

  55. False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant

    Article • Journal of Thrombosis and Haemostasis, June 2010, Wiley

    Marie-Christine Morel-Kopp

  56. Effect of Omega-3 Fish Oil on Cardiovascular Risk in Diabetes

    Article • The Diabetes Educator, June 2010, SAGE Publications

    Dr Bradley J McEwen, Marie-Christine Morel-Kopp

  57. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies

    Article • Thrombosis Research, May 2010, Elsevier

    Marie-Christine Morel-Kopp

  58. Prospective study of early bereavement on psychological and behavioural cardiac risk factors

    Article • Internal Medicine Journal, June 2009, Wiley

    Marie-Christine Morel-Kopp

  59. The association of depression with platelet activation: evidence for a treatment effect

    Article • Journal of Thrombosis and Haemostasis, April 2009, Wiley

    Marie-Christine Morel-Kopp

  60. The Overall Haemostatic Potential (OHP) Assay Detects Abnormalities in Fibrinolytic Factors

    Article • Blood, November 2008, American Society of Hematology

    Marie-Christine Morel-Kopp

  61. Mesenchymal Stem Cells: Isolation, Characterisation and In Vivo Fluorescent Dye Tracking

    Article • Heart Lung and Circulation, October 2008, Elsevier

    Marie-Christine Morel-Kopp

  62. Use of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal results

    Article • Internal Medicine Journal, May 2007, Wiley

    Marie-Christine Morel-Kopp

  63. Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay

    Article • Journal of Thrombosis and Haemostasis, March 2007, Wiley

    Marie-Christine Morel-Kopp

  64. Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients

    Article • Thrombosis and Haemostasis, January 2007, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  65. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?

    Article • Journal of Hypertension, October 2006, Wolters Kluwer Health

    Marie-Christine Morel-Kopp

  66. A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier syndrome (BSS)

    Article • Thrombosis and Haemostasis, January 2005, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  67. Identifying Hypercoagulable States with the Overall Haemostatic Potential (OHP), a Simple Global Haemostasis Assay.

    Article • Blood, November 2004, American Society of Hematology

    Marie-Christine Morel-Kopp

  68. An immediate hemolytic reaction induced by repeated administration of oxaliplatin

    Article • Transfusion, May 2004, Wiley

    Marie-Christine Morel-Kopp

  69. Eleven human platelet systems studied in the Vietnamese and Ma'ohis Polynesian populations

    Article • Tissue Antigens, January 2004, Wiley

    Marie-Christine Morel-Kopp

  70. Green fluorescent protein (GFP) tagged to the cytoplasmic tail of αIIb or β3 allows the expression of a fully functional integrin αIIbβ3: effect of β3GFP on αIIbβ3 ligand binding

    Article • Biochemical Journal, July 2001, Portland Press Ltd.

    Marie-Christine Morel-Kopp

  71. Lack of platelet response to collagen associated with autoantibodies against glycoprotein (GP) Ia/IIa and Ib/IX leading to the discovery of SLE

    Article • Hematology and Cell Therapy, August 1996, Springer Science + Business Media

    Marie-Christine Morel-Kopp

  72. Antiplatelet antibodies during the course of HIV-preventive vaccine trial

    Article • AIDS, April 1996, Wolters Kluwer Health

    Marie-Christine Morel-Kopp

  73. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes

    Article • Human Immunology, April 1996, Elsevier

    Marie-Christine Morel-Kopp

  74. Drawbacks of the MAIPA technique in characterising human antiplatelet antibodies

    Article • Blood Coagulation & Fibrinolysis, March 1996, Wolters Kluwer Health

    Marie-Christine Morel-Kopp

  75. The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: identification of a new mutation on the alpha IIb gene

    Article • Blood, August 1995, American Society of Hematology

    Marie-Christine Morel-Kopp

  76. The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: identification of a new mutation on the alpha IIb gene

    Article • Blood, August 1995, American Society of Hematology

    Marie-Christine Morel-Kopp

  77. Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect

    Article • Transfusion Medicine, June 1995, Wiley

    Marie-Christine Morel-Kopp

  78. Heparin- and Streptokinase-Dependent Platelet-Activating Immunoglobulin G: Mechanism and Diagnosis

    Article • Seminars in Thrombosis and Hemostasis, January 1995, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  79. Maternal Thrombocytopenia During Pregnancy: Diagnosis and Etiology

    Article • Seminars in Thrombosis and Hemostasis, January 1995, Thieme Publishing Group

    Marie-Christine Morel-Kopp

  80. MANAGEMENT OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA

    Article • Vox Sanguinis, July 1994, Wiley

    Marie-Christine Morel-Kopp

  81. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods

    Article • Transfusion Medicine, March 1994, Wiley

    Marie-Christine Morel-Kopp

  82. MHC class II region including TAP genes controls the genetic susceptibility to anti-Gp IB IX autoimmune thrombocytopenia

    Article • Human Immunology, February 1994, Elsevier

    Marie-Christine Morel-Kopp

  83. Management of fetal and neonatal alloimmune thrombocytopenia

    Article • Vox Sanguinis, January 1994, Wiley

    Marie-Christine Morel-Kopp

  84. Neonatal thrombocytopenia and hidden maternal autoimmunity

    Article • British Journal of Haematology, July 1993, Wiley

    Marie-Christine Morel-Kopp

  85. Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura

    Article • Platelets, January 1993, Taylor & Francis

    Marie-Christine Morel-Kopp

  86. Anti-HPA-4b (anti-Yuka) neonatal alloimmune thrombocytopenia: first report in a Caucasian family

    Article • Transfusion Medicine, December 1992, Wiley

    Marie-Christine Morel-Kopp

  87. Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy

    Article • Transfusion Medicine, December 1992, Wiley

    Marie-Christine Morel-Kopp

  88. Polymorphisme des groupes plaquettaires en Provence. Comparaison avec les fréquences des allo-antigènes spécifiques plaquettaires observées dans les autres populations

    Article • Revue Française de Transfusion et d Hémobiologie, January 1992, Elsevier

    Marie-Christine Morel-Kopp

  89. HPA-5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases

    Article • British Journal of Haematology, July 1991, Wiley

    Marie-Christine Morel-Kopp

  90. AIDS vaccine therapy: phase I trial

    Article • The Lancet, July 1990, Elsevier

    Marie-Christine Morel-Kopp

  91. Aeguorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation - dependent calcium movement in response to ADP

    Article • Thrombosis Research, June 1990, Elsevier

    Marie-Christine Morel-Kopp

  92. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia

    Article • British Journal of Haematology, December 1989, Wiley

    Marie-Christine Morel-Kopp

  93. Calcium rise in human platelets elicited by anti-CD9 and -CD41 murine monoclonal antibodies

    Article • Thrombosis Research, September 1989, Elsevier

    Marie-Christine Morel-Kopp

  94. PL2-49, a monoclonal antibody against glycoprotein IIb which is a platelet activator

    Article • British Journal of Haematology, January 1989, Wiley

    Marie-Christine Morel-Kopp